EIF4E Antibody Cat
Total Page:16
File Type:pdf, Size:1020Kb
EIF4E Antibody Cat. No.: 60-600 EIF4E Antibody Formalin-fixed and paraffin-embedded human breast carcinoma reacted with EIF4E antibody (N-term), which was peroxidase- conjugated to the secondary antibody, followed by DAB staining. Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human Predicted species reactivity based on immunogen sequence: Zebrafish, Bovine, Mouse, HOMOLOGY: Rabbit, Rat, Xenopus This EIF4E antibody is generated from rabbits immunized with a KLH conjugated synthetic IMMUNOGEN: peptide between 32-61 amino acids from the N-terminal region of human EIF4E. TESTED APPLICATIONS: IHC-P, WB For WB starting dilution is: 1:1000 APPLICATIONS: For IHC-P starting dilution is: 1:50~100 September 27, 2021 1 https://www.prosci-inc.com/eif4e-antibody-60-600.html PREDICTED MOLECULAR 25 kDa WEIGHT: Properties This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by PURIFICATION: dialysis CLONALITY: Polyclonal ISOTYPE: Rabbit Ig CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: Supplied in PBS with 0.09% (W/V) sodium azide. CONCENTRATION: batch dependent Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies STORAGE CONDITIONS: care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. Additional Info OFFICIAL SYMBOL: EIF4E Eukaryotic translation initiation factor 4E, eIF-4E, eIF4E, eIF-4F 25 kDa subunit, mRNA cap- ALTERNATE NAMES: binding protein, EIF4E, EIF4EL1, EIF4F ACCESSION NO.: P06730 PROTEIN GI NO.: 1352435 GENE ID: 1977 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References eIF4F is a multi-subunit complex, the composition of which varies with external and internal environmental conditions. It is composed of at least EIF4A, EIF4E and EIF4G1/EIF4G3. EIF4E is also known to interact with other partners. The interaction with EIF4ENIF1 mediates the import into the nucleus. Nonphosphorylated EIF4EBP1, EIF4EBP2 BACKGROUND: and EIF4EBP3 compete with EIF4G1/EIF4G3 to interact with EIF4E; insulin stimulated MAP- kinase (MAPK1 and MAPK3) phosphorylation of EIF4EBP1 causes dissociation of the complex allowing EIF4G1/EIF4G3 to bind and consequent initiation of translation. Rapamycin can attenuate insulin stimulation, mediated by FKBPs. this gene also interacts mutually exclusive with EIF4A1 and EIF4A2. REFERENCES: 1) Rychlik,W., J. Biol. Chem. 262 (22), 10434-10437 (1987) September 27, 2021 2 https://www.prosci-inc.com/eif4e-antibody-60-600.html 2) Dorfman,J., Genomics(4), 785-788 (1991) 3) Pelletier,J., Genomics 10 (4), 1079-1082 (1991) 4) Whalen,S.G., J. Biol. Chem. 271 (20), 11831-11837 (1996) ANTIBODIES FOR RESEARCH USE ONLY. For additional information, visit ProSci's Terms & Conditions Page. September 27, 2021 3 https://www.prosci-inc.com/eif4e-antibody-60-600.html.